Oct
2026
Fiera Milano, Italy
Visit us
stand 10H50, CRO
Sever Pharma Solutions
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:Sweden
-
On CPHI since:2023
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 10H50, CRO
Products Featured at CPHI Milan 2026
-
Product Aseptic fill and finish PFS 1mL Long Format and Autoinjector Assembly
We offer solutions for companies that need CMO capacity concerning the aseptic filling of syringes and assembly and packaging of pre-filled syringes and auto-injectors. We will enhance your product by adding value through manufacturing if you require additional capacity or a complete technology transfer. q... -
Product High-potent Dosage Forms up to OEB6
We have the experience, expertise, and facilities at Sever Pharma Solutions to safely work with your high-potent substances. This includes manufacturing products containing APIs that are ranked in the highest occupational exposure bands (OEB) up to and including OEB6.
Our focus on safety starts ... -
Product Hot Melt Extrusion
To successfully develop and manufacture your polymer-based delivery systems, like implants and intra-vaginal rings, we have advanced extrusion capabilities in Malmö (Sweden) and Putnam (US Connecticut). The US site is also a center of expertise for Hot Melt Extrusion (HME).
HME improves the bioa... -
Product Polymer-based delivery systems
Polymer-based dosage forms continuously administer the drug to the patient for an extended period, varying from weeks to years. These controlled-release products are very suitable for specific indications, patient populations, and drugs due to the long duration of action, avoidance of first-pass metabolism...
Sever Pharma Solutions Resources (1)
-
Brochure Who we are - introduction to Sever Pharma Solutions
Sever Pharma Solutions offers a comprehensive range of CDMO Services allowing us to support drug product development from start to finish. Our expertise includes Polymer-BasedDelivery Systems, Highly Potent Compounds (up to OEB6), Hormonal and Controlled DEA Substances (Schedule 3-5).



